More than two in five (42%) or 57.4 million adults under 65 with private insurance could be eligible under clinical criteria for GLP-1 drugs used to treat people with type 2 diabetes, obesity, or excess weight and weight-related health issues, according to a new KFF analysis. Though only about 3% of adults with employer coverage…More
Roche is buying 89bio to get pegozafermin, a drug currently in two Phase 3 studies for the fatty liver disease MASH. Beyond the $2.4 billion payable when the deal closes, another $1.1 billion in contingent value right payments is tied to the achievement of commercial milestones for the projected blockbuster seller. The post Roche’s Metabolic…
Health tech companies made several major funding announcements in May. Here is a list of some of the biggest funding rounds. The post 4 Notable Health Tech Funding Announcements in May appeared first on MedCity News.
Lori Kelley’s deteriorating vision has made it hard for her to find steady work. The 59-year-old, who lives in Harrisburg, North Carolina, closed her nonprofit circus arts school last year because she could no longer see well enough to complete paperwork. She then worked making dough at a pizza shop for a bit. Currently, she…
This volume examines unsupported claims about ivermectin; the promotion of unproven “detox” supplements in response to falsehoods about the spike protein from the COVID-19 virus and vaccine; the unsubstantiated claim that byproducts from medication abortion pills contaminate the water supply; and the renewed debate over ADHD diagnoses and treatments.
RIVERSIDE, Calif. — California’s gubernatorial election is a year away, and the field of primary candidates is still taking shape. But one persistent issue has already emerged as a leading concern: the cost of health care. At a forum Nov. 7 in the Inland Empire, four Democratic candidates vying to succeed Gov. Gavin Newsom vowed…
By DAVID INTROCASO In late July the UN International Court of Justice (ICJ) announced its long-awaited and highly-anticipated climate advisory opinion. The ICJ ruling represents an historic moment in climate accountability. “Obligations of States in Respect of Climate Change” In a rare unanimous decision, the ICJ opinion concluded “a clean, healthy and sustainable environment” is in…
By BENJAMIN EASTON Healthcare’s administrative burden is not a documentation problem. It is a workflow problem. Healthcare’s next leap depends on agentic systems that can actually do the work Over the past year, healthcare organizations have widely adopted generative AI for an array of documentation-related activities such as drafting appeal letters, producing patient-friendly summaries, and…
This isn’t a political issue, it’s a public health challenge with real consequences for kids’ futures. As reality sets in, we must face the possibility of a post-fluoridation era and find new ways to give kids in at-risk communities a fair shot at a healthy smile. The post Beyond Politics: Payer Solutions for Fluoride-free Communities…
That is the title of my paper out today in the Journal of Comparative Effectiveness Research written with co-authors Adam Kittai, Dipen Patel, Nadine Zawadzki, Vikram Shetty, Yazan Barqawi, and Joanna Rhodes. The abstract is below. Aim: To estimate cost savings associated with covalent Bruton’s tyrosine kinase inhibitor (cBTKi) choice in patients with treatment-naive (TN) and…